Osteoarthritis
Osteoarthritis (OA) is the most common form of arthritis, characterized by the progressive degeneration of joint cartilage and underlying bone. It is a prevalent condition that contributes to significant morbidity worldwide[1].
The biological basis of OA is complex, involving mechanical stress, inflammation, and genetic predisposition. Studies have consistently shown a definite genetic component to OA, with heritability observed in various forms, including hand osteoarthritis and radiographic features in peripheral joints and the spine[2]. Genome-wide association studies (GWAS) have identified numerous susceptibility loci across the human genome. These include variants on chromosome 7q22, in the HLA class II/III region, and a prostaglandin-endoperoxide synthase 2 variant associated with knee osteoarthritis[3]. Other research has uncovered novel variants linked to hip osteoarthritis and identified genes likeWNT9A and matrix Gla protein (MGP) involved in hand osteoarthritis[4]. Established risk factors also include increasing age, female sex, obesity, previous joint injury, and certain occupational activities[5].
Clinically, OA manifests with symptoms such as joint pain, stiffness, and reduced mobility, primarily affecting weight-bearing joints like the knees and hips, but also hands and the spine[4]. The severity can range from mild discomfort to debilitating pain, sometimes leading to the need for total joint replacement and, in some cases, persistent neuropathic pain post-surgery[6]. Understanding the genetic architecture of OA is crucial for identifying new therapeutic targets and developing more effective treatments [7].
From a social perspective, OA represents a significant public health challenge due to its high prevalence and the substantial impact it has on individuals’ quality of life and functional independence [1]. The condition contributes to disability and healthcare costs, making research into its genetic underpinnings and potential interventions a priority to alleviate the burden on affected individuals and healthcare systems [1].
Limitations
Section titled “Limitations”Understanding the genetic underpinnings of osteoarthritis (OA) is complex, and current research faces several challenges that impact the interpretation and generalizability of findings. These limitations span methodological hurdles, phenotypic ambiguities, and the intricate multifactorial nature of the disease.
Methodological and Statistical Challenges
Section titled “Methodological and Statistical Challenges”Despite advancements in genome-wide association studies (GWAS) and meta-analyses, identifying all genetic loci associated with osteoarthritis remains challenging. Many potentially interesting loci often do not reach genome-wide significance, necessitating even larger sample sizes for robust discovery -stage OA requiring joint replacement. This variant is considered highly probable as a causal factor, with over 95% posterior probability. Another variant,rs13135092 , also within SLC39A8, may similarly impact zinc transport and contribute to osteoarthritis susceptibility by altering cartilage maintenance and repair pathways. TheANAPC4 gene (Anaphase-Promoting Complex Subunit 4) is a vital component of the anaphase-promoting complex, which is critical for regulating cell division and protein degradation during the cell cycle. The missense variant rs34811474 in ANAPC4is strongly implicated as a causal variant for osteoarthritis, exhibiting a high posterior probability of causality[7]. Dysregulation of the cell cycle in chondrocytes, the primary cells of cartilage, can lead to impaired cartilage repair and contribute to the degenerative processes characteristic of osteoarthritis. Furthermore,TGFA(Transforming Growth Factor Alpha) encodes a ligand for the epidermal growth factor receptor (EGFR), acting as a key integrator of cellular signaling and function, influencing cell growth, proliferation, and differentiation. The intronic variantrs3771501 in TGFAis associated with osteoarthritis at various joint sites and has been specifically linked to reduced minimal joint space width, a common indicator of cartilage degeneration[8]. Other variants, such as rs3755380 and rs7561547 , may also modulate TGFAactivity, thereby affecting cartilage integrity and the inflammatory responses involved in osteoarthritis progression.
Long intergenic non-coding RNAs (lncRNAs) like LINC01865play significant regulatory roles in gene expression, influencing various cellular processes including inflammation, cell proliferation, and programmed cell death, all of which are pertinent to osteoarthritis development. The variantrs62106258 within or near LINC01865may alter its regulatory function, potentially impacting the stability or translation of messenger RNAs involved in cartilage homeostasis and contributing to the imbalance between cartilage synthesis and degradation seen in osteoarthritis, a condition with a definite genetic component[9]. Similarly, LINC01875 is another lncRNA that can modulate gene expression, and variants such as rs6743060 and rs35628463 may influence its activity or expression levels, affecting chondrocyte function and the extracellular matrix composition. Adjacent to LINC01875, the TMEM18gene encodes a transmembrane protein often associated with neuronal function and body mass index (BMI) regulation. Given the strong genetic correlation between osteoarthritis and traits like obesity, variants inTMEM18could indirectly affect joint health through systemic metabolic pathways, as higher BMI and adiposity are supported as roles in osteoarthritis risk[7]. The CAMKV gene (Calcium/Calmodulin Dependent Protein Kinase V) is involved in calcium signaling, a fundamental process for many cellular activities including chondrocyte differentiation and cartilage maintenance. Variants like rs2681781 and rs6446187 in CAMKVmight alter calcium signaling pathways within joint tissues, potentially disrupting the normal physiological responses of chondrocytes to mechanical stress or inflammatory stimuli, thus increasing osteoarthritis risk.
The FYCO1 gene (FYVE and coiled-coil domain containing 1) is involved in autophagy and endosomal trafficking, processes critical for cellular waste removal and nutrient recycling. Variants like rs71325101 and rs13079478 in FYCO1could impair these cellular maintenance mechanisms in chondrocytes, leading to the accumulation of damaged components and contributing to cartilage degeneration in osteoarthritis. TheGPRC5B (G Protein-Coupled Receptor Class C Group 5 Member B) and GPR139 (G Protein-Coupled Receptor 139) genes encode orphan G protein-coupled receptors, which are involved in diverse cellular signaling pathways. Variants such as rs12446632 in GPRC5B and rs8046312 in GPR139may alter receptor activity or expression, thereby influencing cellular responses to various stimuli within the joint environment; such alterations could impact inflammation, pain perception, or cell survival in the context of osteoarthritis, a disease with significant genetic correlation to various traits[8]. XCR1 (Chemokine (C Motif) Receptor 1) and CCR3 (Chemokine (C-C Motif) Receptor 3) are genes encoding chemokine receptors, which play crucial roles in immune cell migration and inflammatory responses. Variants like rs34460587 in XCR1 and rs71327024 in CCR3could modulate the inflammatory cascade within the joint, influencing the recruitment of immune cells and the production of pro-inflammatory cytokines, which are key drivers of osteoarthritis pathology. Finally,TACC3 (Transforming Acidic Coiled-Coil Containing Protein 3) is involved in regulating microtubule stability and cell division, while FGFR3(Fibroblast Growth Factor Receptor 3) is a receptor tyrosine kinase critical for bone and cartilage development and growth plate regulation. Variants likers12509303 in TACC3 and rs11731421 in FGFR3may affect chondrocyte proliferation, differentiation, or the structural integrity of cartilage, thereby contributing to the genetic susceptibility to osteoarthritis, a condition where novel therapeutic targets are being identified through genome-wide analyses[7].
Classification, Definition, and Terminology
Section titled “Classification, Definition, and Terminology”Defining Osteoarthritis: A Chronic Joint Disorder
Section titled “Defining Osteoarthritis: A Chronic Joint Disorder”Osteoarthritis (OA) is recognized as the most prevalent form of arthritis, contributing significantly to global morbidity[3]. It is characterized as a complex joint disorder involving structural changes within the joint, where articular cartilage, an avascular and aneural tissue, undergoes alterations [8]. These structural changes often manifest before the onset of noticeable symptoms, highlighting its progressive nature [8]. Key risk factors that contribute to the development and progression of OA include advanced age, female sex, obesity, previous joint injuries, and sustained physical stress on the joints from work or other activities[10]. Genetic predispositions also play a significant role, with studies indicating heritable components in both peripheral joints and spinal disc degeneration [11]; [2].
Classification and Subtypes of Osteoarthritis
Section titled “Classification and Subtypes of Osteoarthritis”Osteoarthritis is broadly classified by the anatomical location of the affected joints, with common subtypes including hand, knee, and hip osteoarthritis[3]; [1]; [4]. Severity is commonly graded using the Kellgren-Lawrence (KL) scaling system, which categorizes radiographic findings from grade 0 (no osteoarthritis) to grade 4 (severe osteoarthritis)[12]. Furthermore, specific criteria exist for defining generalized osteoarthritis, such as for hand OA, which requires involvement of three or more joints with a KL grade of ≥2, including specific digital interphalangeal (DIP) and proximal interphalangeal (PIP) joints, and bilateral hand involvement[12]. This nosological approach helps differentiate between localized and more widespread forms of the disease.
Diagnostic and Measurement Criteria
Section titled “Diagnostic and Measurement Criteria”The diagnosis of osteoarthritis is typically made by a physician, often relying on a combination of clinical assessment and imaging[10]. For research and detailed clinical evaluation, specific radiographic criteria are employed, such as those defining radiographic hand OA: the presence of three or more joint involvements with a Kellgren-Lawrence grade of ≥2, at least one DIP joint of digits 2–5, and two of the three involved joints within a joint group (DIP, PIP, or carpometacarpal (CMC)), while excluding more than three swollen metacarpophalangeal (MCP) joints by clinical examination [12]. Measurement approaches also involve evaluating associated metabolic factors, such as body mass index (BMI), waist circumference, and fat mass, which have been positively correlated with OA risk[10]; [8]. While some inflammatory markers like serum C-reactive protein (CRP) have been investigated, they do not consistently show significant differences between OA and non-OA groups[10].
Signs and Symptoms
Section titled “Signs and Symptoms”Osteoarthritis (OA) is the most prevalent form of arthritis, characterized by a range of clinical presentations that affect individuals differently. Its manifestation involves both subjective symptoms and objective signs, with variability influenced by genetic, demographic, and environmental factors.
Clinical Manifestations and Presentation Patterns
Section titled “Clinical Manifestations and Presentation Patterns”A primary clinical symptom of osteoarthritis is persistent pain, which can become chronic and significantly impact quality of life[13]. Studies indicate that individuals diagnosed with OA often report pain even years after their initial diagnosis, highlighting the long-term nature of this symptom[13]. OA accounts for substantial morbidity, reflecting its widespread impact on health and daily functioning [1]. The disease can affect various joint sites, including the knee, hip, and hand, leading to diverse clinical phenotypes and presentation patterns specific to the affected joint[14], [15], [1], [16], [13], [4].
Assessment and Measurement Approaches
Section titled “Assessment and Measurement Approaches”The assessment of osteoarthritis typically involves a combination of objective and subjective measures. Radiography is a key diagnostic tool, especially for knee osteoarthritis, where it helps identify structural changes within the joint[14], [15], [1], [16]. Clinical diagnosis often incorporates hospital-diagnosed criteria alongside patient self-reported disease status, which are both utilized in large research cohorts to define OA prevalence and characteristics[7], [2].
Beyond imaging and clinical history, objective physical measurements such as Body Mass Index (BMI), waist circumference, and fat mass are frequently assessed, as these factors are known to correlate with OA risk and progression[13]. Genetic studies, including Genome-Wide Association Studies (GWAS), are increasingly employed to identify polygenetic variants and susceptibility loci associated with OA risk, providing insights into the disease’s underlying biology and potential future biomarkers or diagnostic strategies[14], [15], [1], [16], [13].
Variability, Heterogeneity, and Diagnostic Significance
Section titled “Variability, Heterogeneity, and Diagnostic Significance”Osteoarthritis exhibits considerable inter-individual variability and heterogeneity in its presentation and progression. Age is a significant factor, with the incidence of OA increasing notably with advancing age; individuals aged 55 years and older face a substantially higher risk, which further escalates in those aged 65 and above[13]. Sex differences are also prominent, as women have a significantly higher incidence and risk of OA compared to men [13].
The phenotypic diversity of OA is evident in its manifestation across distinct joint sites like the knee, hip, and hand, each potentially having unique genetic underpinnings, although genetic correlations between sites such as the hip and knee suggest some shared mechanisms [1], [13], [4], [2]. Various risk factors, including obesity, type 2 diabetes, joint injuries, repeated physical stress, and socioeconomic factors like lower education and income, influence the likelihood and presentation of OA, serving as important clinical correlations and prognostic indicators for diagnosis and management[13].
Causes
Section titled “Causes”Osteoarthritis (OA) is a complex multifactorial condition influenced by a combination of genetic predispositions, environmental exposures, and intrinsic biological processes. Its development involves a progressive deterioration of articular cartilage and changes in the underlying bone, often leading to pain, stiffness, and reduced joint function.
Genetic Predisposition and Architecture
Section titled “Genetic Predisposition and Architecture”A significant genetic component underpins the susceptibility to osteoarthritis, with twin studies and heritability estimates confirming its inherited nature, particularly for radiographic forms in peripheral joints and the spine . It is a debilitating joint disease impacting various parts of the body, including the knee, hip, hand, finger, and thumb[17]. The development and progression of OA involve intricate biological mechanisms spanning molecular, cellular, and tissue levels.
The Complex Nature of Osteoarthritis and Joint Tissues
Section titled “The Complex Nature of Osteoarthritis and Joint Tissues”Osteoarthritis represents a breakdown in the normal physiology of joint tissues, leading to pain and functional impairment. This condition accounts for significant morbidity, affecting specific joints such as the knee, hip, and hands[3]. Beyond genetic predisposition, several environmental and lifestyle factors contribute to OA risk, including obesity, type 2 diabetes, previous joint injuries, and repeated physical stress on the joints[10]. These factors often initiate or exacerbate homeostatic disruptions within the joint, setting the stage for disease progression.
At the tissue level, OA is characterized by the degeneration of cartilage, the smooth connective tissue that covers the ends of bones in a joint. While not explicitly detailed as a primary focus in all studies, the context of meniscal degeneration being a target for prevention and treatment underscores the critical interactions between various joint components like cartilage and menisci [14].
Genetic Predisposition and Regulatory Networks
Section titled “Genetic Predisposition and Regulatory Networks”Osteoarthritis has a definite genetic component, with numerous genome-wide association studies (GWAS) identifying specific genetic loci and variants associated with susceptibility[9]. For instance, a notable susceptibility locus for knee osteoarthritis has been consistently identified and confirmed on chromosome 7q22 through multiple GWAS and meta-analyses[3]. Additionally, novel variants in the HLA class II/III region have been linked to knee osteoarthritis, suggesting an involvement of immune-related pathways in disease pathogenesis . The involvement of meniscal degeneration as a target for prevention and treatment further emphasizes the interconnectedness of various joint tissues and their collective contribution to disease progression -stage consequences of prolonged homeostatic imbalance and the failure of compensatory responses within the joint. The systemic consequences of osteoarthritis, characterized by substantial morbidity, extend beyond the affected joint, impacting overall quality of life and healthcare burden[3].
Pathways and Mechanisms
Section titled “Pathways and Mechanisms”Osteoarthritis (OA) is a complex degenerative joint disease characterized by the breakdown of cartilage, subchondral bone remodeling, and synovial inflammation. Its pathogenesis involves a multifaceted interplay of genetic predispositions, cellular signaling, metabolic dysregulation, and environmental factors, all contributing to the progressive deterioration of joint tissues. Research indicates that OA arises from a systems-level dysregulation of normal joint homeostasis, involving numerous interconnected molecular pathways and regulatory mechanisms[8].
Genetic Architecture and Transcriptional Regulation
Section titled “Genetic Architecture and Transcriptional Regulation”The foundational mechanisms of osteoarthritis often stem from genetic predisposition, with numerous susceptibility loci identified through genome-wide association studies (GWAS). For instance, variants on chromosome 7q22 have been consistently associated with an increased risk of knee OA[16], [1]. Such genetic determinants, including those affecting radiographic knee OA in diverse populations, suggest that specific gene regulations are perturbed, influencing the expression levels or functional properties of proteins critical for joint integrity [14], [15]. The identification of a variant in MCF2Lassociated with OA further underscores how alterations in gene sequences can contribute to disease susceptibility, potentially by affecting transcriptional regulation and the downstream production of proteins involved in cellular processes[18].
Inflammatory and Developmental Signaling Pathways
Section titled “Inflammatory and Developmental Signaling Pathways”Central to osteoarthritis pathogenesis are various signaling pathways that govern cellular responses and tissue remodeling. The prostaglandin-endoperoxide synthase 2 (PTGS2) gene, encoding COX-2, has a variant associated with knee OA risk, highlighting the critical role of inflammatory signaling cascades in disease progression[19]. Activation of this pathway leads to the production of prostaglandins, potent mediators of inflammation and pain within the joint. Furthermore, the NOD/RIPK2 signaling pathway contributes to OA susceptibility, indicating an involvement of innate immune responses and cell death pathways in the chronic inflammatory state of the joint[20]. Concurrently, BMP (Bone Morphogenetic Protein) signaling, essential for mesenchymal stem cell differentiation and bone formation, plays a crucial role in cartilage and bone homeostasis, and its dysregulation can impact repair mechanisms and contribute to pathological remodeling observed in OA[20].
Extracellular Matrix Homeostasis and Metabolic Interventions
Section titled “Extracellular Matrix Homeostasis and Metabolic Interventions”The maintenance of the extracellular matrix (ECM) is vital for cartilage function, and its dysregulation is a hallmark of OA. Matrix Gla protein (MGP), for example, has been identified through functional studies as playing a significant role in osteoarthritis of the hand[13]. MGP is a vitamin K-dependent protein, implying that post-translational modifications, such as gamma-carboxylation, are critical for its function in regulating calcification and maintaining matrix integrity. Beyond specific proteins, broader metabolic pathways are implicated, as polygenetic variants related to OA risk interact with dietary factors such as energy, protein, fat, and alcohol intake[10]. These interactions suggest that metabolic regulation and flux control, impacting biosynthesis and catabolism of joint components, are profoundly influenced by both genetic background and environmental factors, collectively contributing to disease manifestation.
Systems-Level Integration and Pathway Crosstalk
Section titled “Systems-Level Integration and Pathway Crosstalk”Osteoarthritis is increasingly understood as a disease of systems-level dysregulation, where numerous pathways interact and influence each other in a complex network. The polygenic nature of OA means that multiple genetic variants collectively contribute to risk, with their effects often being modulated by environmental factors, leading to intricate pathway crosstalk[10], [8]. This integrated network includes feedback loops and compensatory mechanisms that attempt to maintain joint homeostasis, but ultimately fail in the face of persistent genetic and environmental stressors. An example of such broad systems-level integration is the observed shared genetic contribution between osteoarthritis and outcomes of COVID-19, suggesting common underlying immune or inflammatory pathways that can influence susceptibility to seemingly disparate conditions[21]. Understanding these hierarchical regulations and emergent properties of the entire biological network is crucial for identifying comprehensive therapeutic targets.
Clinical Relevance
Section titled “Clinical Relevance”Osteoarthritis (OA) is the most prevalent form of arthritis, leading to substantial morbidity worldwide[22]. Understanding its diverse clinical relevance, from genetic predispositions to lifestyle interactions and potential therapeutic targets, is crucial for effective patient care. Research efforts have illuminated various aspects, including risk stratification, prognostic indicators, and the interplay with comorbidities, offering avenues for personalized medicine and prevention strategies.
Genetic and Population-Specific Risk Factors
Section titled “Genetic and Population-Specific Risk Factors”Genetic studies play a significant role in identifying individuals at higher risk for developing osteoarthritis and in understanding its diverse presentations. Genome-wide association studies (GWAS) have confirmed specific susceptibility loci for OA, such as on chromosome 7q22 for knee OA, and identified novel variants associated with hip OA[23]. Furthermore, variants in genes like MCF2L, matrix Gla protein (MGP), and WNT9A have been linked to general OA or specific forms like hand OA [4]. These genetic insights contribute to diagnostic utility by enabling earlier risk assessment and supporting personalized medicine approaches, considering that genetic determinants for radiographic knee OA can vary across different populations, such as African Americans and North American Caucasians [14]. Polygenetic variants, which combine the effects of multiple genes, also contribute to overall OA risk, highlighting the complex genetic architecture of the disease[10].
Prognostic Indicators and Disease Trajectories
Section titled “Prognostic Indicators and Disease Trajectories”Identifying prognostic indicators is essential for predicting disease progression, treatment response, and long-term implications for patients. Age is a significant factor, with participants aged 55 years or older having a 2.5-times higher risk of OA, and those aged 65 years or older showing a 6.4-times higher risk compared to younger individuals[10]. Women also face a higher risk of OA, with a 3.2-times greater incidence than men [10]. It is important to note that structural changes within the joint often precede the onset of clinical symptoms, indicating a window for potential early intervention before symptomatic disease manifests[8]. The severity of hand osteoarthritis has also been associated with the need for total knee joint replacements, independently of body mass index (BMI), suggesting complex long-term implications and disease interconnections[24].
Lifestyle, Comorbidities, and Prevention Strategies
Section titled “Lifestyle, Comorbidities, and Prevention Strategies”Osteoarthritis risk is significantly influenced by lifestyle factors and comorbidities, providing critical targets for risk stratification and prevention. A strong causal effect of BMI and other obesity-related measures on OA has been established, corroborating findings from observational studies and emphasizing obesity management as a key prevention strategy[8]. Individuals with OA tend to have higher BMI, waist circumference, and fat mass compared to those without the condition [10]. Beyond physiological factors, socioeconomic status also plays a role, with lower education and income levels being associated with a higher incidence of OA[10]. The interaction between polygenetic variants and dietary intake, including energy, protein, fat, and alcohol, further underscores the potential for personalized prevention strategies that combine genetic risk assessment with tailored lifestyle interventions[10].
Translational Impact: Diagnostics and Therapeutics
Section titled “Translational Impact: Diagnostics and Therapeutics”The identification of genetic and molecular underpinnings of osteoarthritis has profound implications for the development of advanced diagnostic tools and novel therapeutic targets. Specific genes, such asmatrix Gla protein (MGP) and WNT9A, identified through genome-wide association and functional studies, offer promising avenues for understanding disease mechanisms and developing targeted interventions for conditions like hand OA[4]. Large-scale genome-wide analyses using data from cohorts like the UK Biobank are actively contributing to the identification of new therapeutic targets, paving the way for future drug development and more effective treatment selection [7]. While current treatment selection is often based on symptomology and radiographic findings, these genetic insights lay the groundwork for a future where monitoring strategies and treatment choices could be guided by an individual’s specific genetic profile and risk factors, moving towards a more precise and personalized approach to OA management.
Key Variants
Section titled “Key Variants”| RS ID | Gene | Related Traits |
|---|---|---|
| rs62106258 | LINC01865 | waist-hip ratio body mass index dental caries, dentures lean body mass dentures |
| rs6743060 rs35628463 | LINC01875 - TMEM18 | waist-hip ratio osteoarthritis |
| rs2681781 rs6446187 | CAMKV | osteoarthritis |
| rs13107325 rs13135092 | SLC39A8 | body mass index diastolic blood pressure systolic blood pressure high density lipoprotein cholesterol measurement mean arterial pressure |
| rs3755380 rs3771501 rs7561547 | TGFA | osteoarthritis |
| rs34811474 | ANAPC4 | body mass index intelligence heel bone mineral density balding measurement urate measurement |
| rs71325101 rs13079478 | FYCO1 | osteoarthritis |
| rs12446632 rs8046312 | GPRC5B - GPR139 | age at menarche body mass index obesity physical activity measurement, body mass index hip circumference |
| rs34460587 rs71327024 | XCR1 - CCR3 | osteoarthritis |
| rs12509303 rs11731421 | TACC3 - FGFR3 | osteoarthritis |
Frequently Asked Questions About Osteoarthritis
Section titled “Frequently Asked Questions About Osteoarthritis”These questions address the most important and specific aspects of osteoarthritis based on current genetic research.
1. My mom has bad knees, will I get joint pain like her?
Section titled “1. My mom has bad knees, will I get joint pain like her?”Yes, there’s a definite genetic component to osteoarthritis, meaning it can run in families. Studies show heritability for various forms, including knee osteoarthritis, so if your mom has it, you might have a higher predisposition. However, other factors like age, previous joint injury, and obesity also play a role in developing the condition.
2. Why do my joints hurt more than my friends’ even though we’re the same age?
Section titled “2. Why do my joints hurt more than my friends’ even though we’re the same age?”Your genetic makeup likely influences why your joints might feel worse. We know that specific genetic variants, for example on chromosome 7q22 or in the HLA region, contribute to osteoarthritis susceptibility. While increasing age is a general risk factor for everyone, these genetic differences can make some individuals more prone to cartilage degeneration and pain earlier or more severely than others.
3. Can heavy exercise overcome my family’s joint problems?
Section titled “3. Can heavy exercise overcome my family’s joint problems?”While genetics definitely play a significant role in osteoarthritis susceptibility, lifestyle choices like exercise are still important. Regular, appropriate exercise can help manage weight and strengthen supporting muscles, which are established risk factors for osteoarthritis. However, even with a healthy lifestyle, a strong genetic predisposition might still mean you develop osteoarthritis, but it could potentially influence its severity or onset.
4. Why did my grandma’s hands get so bad, but my uncle’s hips?
Section titled “4. Why did my grandma’s hands get so bad, but my uncle’s hips?”Yes, the specific joints affected by osteoarthritis can be influenced by genetics. For example, variants in genes likeWNT9A and matrix Gla protein (MGP) have been linked specifically to hand osteoarthritis. Other genetic loci might predispose individuals more to knee or hip osteoarthritis, explaining why different family members might experience the condition in different joints.
5. Are women more likely to get severe joint pain?
Section titled “5. Are women more likely to get severe joint pain?”Yes, female sex is an established risk factor for osteoarthritis. While the exact genetic reasons for this difference are still being researched, it’s clear that women, on average, have a higher likelihood of developing and experiencing more severe osteoarthritis than men.
6. My old knee injury – does it make my genes for joint pain worse?
Section titled “6. My old knee injury – does it make my genes for joint pain worse?”Yes, a previous joint injury is an established risk factor for osteoarthritis, and it can interact with your genetic predisposition. While your genes might make you more susceptible to osteoarthritis, an injury can accelerate or worsen the condition in that specific joint. It’s often a combination of your inherited vulnerability and external factors.
7. Does being overweight make my joint pain genes act up?
Section titled “7. Does being overweight make my joint pain genes act up?”Absolutely. Obesity is a major established risk factor for osteoarthritis. If you carry genetic variants that predispose you to osteoarthritis, being overweight can increase the mechanical stress on your joints, particularly weight-bearing ones like knees and hips. This added stress, combined with inflammation often associated with obesity, can accelerate the progression of osteoarthritis in genetically susceptible individuals.
8. If a DNA test shows OA risk, what can I actually do?
Section titled “8. If a DNA test shows OA risk, what can I actually do?”A DNA test showing an osteoarthritis risk can provide valuable information about your predisposition. While it can’t change your genes, knowing your risk might encourage you to be more proactive with modifiable risk factors like maintaining a healthy weight, avoiding joint injuries, and engaging in appropriate exercise. This awareness can help you make informed lifestyle choices to potentially delay onset or reduce severity.
9. Why did my joint pain start so much younger than others?
Section titled “9. Why did my joint pain start so much younger than others?”The age of osteoarthritis onset can vary significantly, and genetics play a role. Some individuals inherit genetic variants that predispose them to earlier cartilage degeneration or more aggressive disease progression. While increasing age is a general risk factor, specific genetic influences, alongside factors like previous joint injury or obesity, can lead to symptoms appearing at a younger age.
10. Does my ethnic background change my joint problem risk?
Section titled “10. Does my ethnic background change my joint problem risk?”Yes, there can be differences in genetic risk factors across ethnic backgrounds. Research has identified genetic determinants of radiographic knee osteoarthritis in African Americans, and studies are ongoing to uncover how specific genetic variants might be more prevalent or have different effects in various populations. This means your ancestry could influence your specific genetic susceptibility to osteoarthritis.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
Section titled “References”[1] Evangelou E et al. “A meta-analysis of genome-wide association studies identifies novel variants associated with osteoarthritis of the hip.”Ann Rheum Dis, 2014, vol. 73, no. 1, pp. 213-219. PubMed, PMID: 23989986.
[2] Bijkerk C, Houwing-Duistermaat JJ, Valkenburg HA, et al. “Heritabilities of radiologic osteoarthritis in peripheral joints and of disc degeneration of the spine.”Arthritis Rheum, 1999, vol. 42, no. 8, pp. 1729-1735. PubMed, PMID: 10446874.
[3] Evangelou E et al. “Meta-analysis of genome-wide association studies confirms a susceptibility locus for knee osteoarthritis on chromosome 7q22.”Ann Rheum Dis, 2011, vol. 70, no. 3, pp. 349-353. PubMed, PMID: 21068099.
[4] Boer CG et al. “Genome-wide association of phenotypes based on clustering patterns of hand osteoarthritis identifyWNT9Aas novel osteoarthritis gene.”Ann Rheum Dis, 2020, vol. 79, no. 1, pp. 123-130. PubMed, PMID: 33055079.
[5] Felson DT. “Risk factors for osteoarthritis: understanding joint vulnerability.”Clin Orthop Relat Res, 2004, no. 427, pp. S16-S21. PubMed, PMID: 15480060.
[6] Warner SC et al. “Genome-wide association scan of neuropathic pain symptoms post total joint replacement highlights a variant in the protein-kinase C gene.”Eur J Hum Genet, 2017, vol. 25, no. 4, pp. 446-451. PubMed, PMID: 28051079.
[7] Tachmazidou I et al. “Identification of new therapeutic targets for osteoarthritis through genome-wide analyses of UK Biobank data.”Nat Genet, 2019, vol. 51, no. 3, pp. 477-483. PubMed, PMID: 30664745.
[8] Zengini E et al. “Genome-wide analyses using UK Biobank data provide insights into the genetic architecture of osteoarthritis.”Nat Genet, 2018, vol. 50, no. 4, pp. 549-558. PubMed, PMID: 29559693.
[9] Nakajima M et al. “New sequence variants in HLA class II/III region associated with susceptibility to knee osteoarthritis identified by genome-wide association study.”PLoS One, 2010, vol. 5, no. 3, e9723. PubMed, PMID: 20305777.
[10] Park S et al. “Polygenetic Variants Related to Osteoarthritis Risk and Their Interactions with Energy, Protein, Fat, and Alcohol Intake in Adults in a Large Cohort.”Diagnostics (Basel), 2022, vol. 12, no. 2, 340. PubMed, PMID: 35204431.
[11] Spector TD, Cicuttini F, Baker J, et al. “Genetic influences on osteoarthritis in women: a twin study.”BMJ, 1996, vol. 312, no. 7036, pp. 940-943. PubMed, PMID: 8616305.
[12] Khosasih, V., et al. “A Functional Polymorphism Downstream of Vitamin A Regulator GeneCYP26B1Is Associated with Hand Osteoarthritis.”Int J Mol Sci, vol. 24, no. 3, 2023, p. 2898.
[13] den Hollander W et al. “Genome-wide association and functional studies identify a role for matrix Gla protein in osteoarthritis of the hand.”Ann Rheum Dis, 2018, vol. 77, no. 1, pp. 108-116. PubMed, PMID: 28855172.
[14] Liu Y et al. “Genetic Determinants of Radiographic Knee Osteoarthritis in African Americans.”J Rheumatol, 2017, vol. 44, no. 11, pp. 1625-1632. PubMed, PMID: 28916551.
[15] Yau MS et al. “Genome-Wide Association Study of Radiographic Knee Osteoarthritis in North American Caucasians.”Arthritis Rheumatol, 2016, vol. 68, no. 12, pp. 2928-2936. PubMed, PMID: 27696742.
[16] Kerkhof HJ et al. “A genome-wide association study identifies an osteoarthritis susceptibility locus on chromosome 7q22.”Arthritis Rheum, 2010, vol. 62, no. 2, pp. 499-510. PubMed, PMID: 20112360.
[17] Hatzikotoulas, K. “Translational genomics of osteoarthritis in 1,962,069 individuals.”Nature, vol. 628, no. 8008, 2024, pp. 583-591. PMID: 40205036.
[18] Day-Williams, A. G., et al. “A variant in MCF2L is associated with osteoarthritis.”Am J Hum Genet, vol. 89, no. 2, 2011, pp. 446-50, PMID: 21871595.
[19] Valdes AM et al. “Genome-wide association scan identifies a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritis.”Am J Hum Genet, 2008, vol. 82, no. 5, pp. 1231-1240. PubMed, PMID: 18471798.
[20] Styrkarsdottir U et al. “Meta-analysis of erosive hand osteoarthritis identifies four common variants that associate with relatively large effect.”Ann Rheum Dis, 2023, vol. 82, no. 6, pp. 830-835. PubMed, PMID: 36931692.
[21] Huang, Y. X., et al. “A shared genetic contribution to osteoarthritis and COVID-19 outcomes: a large-scale genome-wide cross-trait analysis.”Front Immunol, vol. 14, 2023, p. 1184958. PMID: 37398645.
[22] Evangelou, E., et al. “Meta-analysis of genome-wide association studies confirms a susceptibility locus for knee osteoarthritis on chromosome 7q22.”Ann Rheum Dis, vol. 69, no. 12, 2010, pp. 1991-98, PMID: 21068099.
[23] Evangelou, E, et al. “A meta-analysis of genome-wide association studies identifies novel variants associated with osteoarthritis of the hip.”Ann Rheum Dis, vol. 73, no. 6, 2013, pp. 1197-201.
[24] Jonsson, H., et al. “Hand osteoarthritis severity is associated with total knee joint replacements independently of BMI. The Ages-Reykjavik Study.”Open Rheumatol J, vol. 5, 2011, pp. 7-12, PMID: 21552415.